Transcatheter aortic valve intervention through the axillary artery for the treatment of severe aortic stenosis  by Asgar, Anita W. et al.
the mid and distal thirds of the right wall of the trachea and is
directed to the upper lobe. It is more common in male pa-
tients and in children with other congenital abnormalities
and should always be suspected when persisting respiratory
morbidity in childhood is present. Three types of tracheal
bronchi are described by Doolittle and Mair,1 including a tra-
cheal diverticulum, a fully developed supranumerary tra-
cheal bronchus, and a high apical lobe, as was present in
our case.
The finding of a tracheal bronchus was new for us, and
only 4 cases have been published in cases of lung trans-
plant.2-5 In 1 of these 4, the tracheal bronchus was present
in the recipient and not in the donor lung.2 The other 3 recip-
ients underwent sequential bilateral lung transplant,3-5 but
only in 2 cases was the right upper lobe preserved and reim-
planted.4,5 Brichon and colleagues3 excised the tracheal
bronchus because it only supplied the right apical segment
of the right upper lobe, in contrast to the 2 other cases in
which the tracheal bronchus supplied the whole right upper
lobe, as was also the case for us. Reconstruction techniques
to preserve this right upper lobe were different. Schmidt and
colleagues5 excised the tracheal bronchus and made it part
of the anastomosis of the right donor lung (Figure 2, B),
whereas Sekine and associates4 performed a carinoplasty
in the recipient and a donor patch with the orifice of the tra-
cheal bronchus and the intermediate bronchus, constructing
an end-to-end anastomosis between the carina of the recipi-
ent and the right donor patch (Figure 2, C). A theoretic tech-
nical option includes an anastomosis of the donor trachea to
the recipient right main bronchus. This leaves the left main
bronchial stump, however, which may give rise to a stump
fistula, and an anastomosis is created at the tracheal level,
with a higher risk of ischemic complications (Figure 2, D).
Because of the limited number of case reports published, it
was difficult to select a technique. Although in our opinion
the technique of Schmidt and colleagues5 carries a higher
theoretic risk of stenosis, the technique of Sekine and asso-
ciates4 carries a higher risk of airway ischemia because it is
a true tracheal anastomosis.
Physicians involved in the Antwerp Lung Transplant Pro-
gram are as follows, in alphabetic order: Drs Ivo Deblier,
Rudi Depaep, Koen De Decker, Wilfried De Backer, Bjorn
Dieriks, Jeroen Hendriks, Annelies Janssens, Philip Jorens,
Patrick Lauwers, Inez Rodrigus, Bernard Stockman, Pieter
ten Broecke, and Paul Van Schil.
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femoral route can be difficult in patients with small or dis-
eased iliofemoral arterial systems that either prevent access,
result in procedural failure, or cause major vascular injury.
The transapical approach avoids these problems; however,
the apex of the left ventricle can be a friable and unforgiving
structure in the older patient. In addition, a small anterolat-
eral thoracotomy is required for the transapical approach,
and this can be a problem in cases of severe respiratory
dysfunction. We describe a trans–axillary artery technique
for TAVI in a patient with severe lung disease and peripheral
vascular disease to illustrate this approach, along with its
potential advantages and limitations.ardiovascular Surgery c Volume 137, Number 3 773
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The patient was a 71-year-old woman with a long history
of bronchiectasis and Pseudomonas colonization. She was
seen for increasing breathlessness during the previous 9
months resulting in numerous hospitalizations. She was
found to have no significant deterioration in her preexisting
respiratory function. Cardiac investigations determined the
presence of severe aortic stenosis, with a peak transvalvular
gradient of 97 mm Hg and a valve area of 0.63 cm2. Angiog-
raphy revealed nonsignificant coronary artery disease but bi-
lateral small and diffusely diseased femoral arteries.
The patient was subsequently discussed at our Structural
Heart Multi-Disciplinary Meeting and was considered to
face a prohibitively high risk with conventional aortic valve
replacement. She was referred to our TAVI program, and
protocol-driven transthoracic echocardiography and aortog-
raphy confirmed adequate anatomic parameters for trans-
catheter valve replacement. The small diseased femoral
arteries made the transfemoral approach unsuitable. In light
of her significant respiratory dysfunction, we believed that
a small thoracotomy would also pose a significant risk. An-
giography demonstrated a healthy aortic arch with nondi-
seased and good-sized left subclavian and axillary arteries,
and the decision was made to proceed through the axillary
approach.
The proximal axillary artery was exposed through a small
infraclavicular incision, and the 18F sheath was inserted
through a transverse arteriotomy. The tip of the sheath was
advanced into the mid ascending aorta (Figure 1), and the
CoreValve self-expanding nitinol prosthesis (CoreValve
Inc, Irvine, Calif) was implanted in the standard manner
FIGURE 1. Positioning of delivery sheath into aorta through axillary
artery.774 The Journal of Thoracic and Cardiovascular Su(Figure 2). The prosthesis was well positioned, with no sig-
nificant residual transvalvular gradient and only trivial aortic
regurgitation. The patient made an uneventful recovery,
apart from high-grade atrioventricular block necessitating
a permanent pacemaker. At 5 months after the procedure,
she was doing well, her symptomatic status has improved
markedly, and she was delighted with the outcome.
DISCUSSION
TAVI is an emerging field with the potential to provide re-
lief of aortic stenosis for a high-risk patient population.3,4
There still are many as yet unresolved difficulties with these
technologies. Two of the major concerns are the access route
to the diseased valve and the ability to accurately position
the prosthesis.5 Although smaller sheathes and other im-
provements in technology will facilitate a transfemoral
approach, this access route will still be challenging in a sig-
nificant proportion of cases for the foreseeable future. The
transapical route is an option for these patients and may
have some advantages with respect to ease of device posi-
tioning and implantation. It may not, however, be suitable
for patients with severe respiratory dysfunction.
The axillary approach is simple and familiar to cardiac
surgeons. The subclavian and proximal axillary arteries are
usually good-sized vessels and are often free of atheroscle-
rotic disease. We have used this approach successfully for
2 additional patients; in all 3 cases, exposure of the vessel,
insertion and removal of the 18F sheath, and vessel repair
were easy and uncomplicated. This approach provided
good stability of the sheath and valve delivery system,
FIGURE 2. Deployment of CoreValve prosthesis (CoreValve Inc, Irvine,
Calif) into aortic position.rgery c March 2009
Brief Communicationswith what appeared to be simpler device positioning and im-
plantation relative to the transfemoral approach. A patent left
internal thoracic artery graft is probably a contraindication to
a left axillary approach. The potential to compromise innom-
inate artery flow is a relative contraindication to the right
axillary approach.
The trans–axillary artery approach offers an additional
tool in the new armamentarium for the treatment of aortic
stenosis in patients who are candidates for TAVI but who
have significant respiratory dysfunction and problematic
iliofemoral access precluding the other available techniques.
We also believe that it offers some advantages relative to the
transfemoral and transapical approaches and is worthy of
evaluation in a broader patient population as an alternative
access route.Palliative bidirectional Glenn anasto
metastasis in the right ventricle from
after nephrectomy
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We report a patient with late renal cell carcinoma metastasis
to the right ventricle 17 years after radical nephrectomy. The
unresectable huge metastasis caused hemodynamic impair-
ment due to right ventricular inflow and outflow tract ob-
struction, which was managed by means of partial excision
of right ventricular intracavity tumor, tricuspid valve replace-
ment, and bidirectional cavopulmonary anastomosis.
CLINICAL SUMMARY
A 53-year-old woman was admitted in a local hospital be-
cause of right-heart failure, including 2-month-old palpita-
tion and dyspnea on exertion. Seventeen years earlier, she
had undergone right nephrectomy for a high-grade (G3)
clear cell–type renal cell carcinoma (RCC) (pT1 bN0 M0).
Echocardiography showed that the massive right ventricular
intracavity mass obliterated the right ventricular cavity. Peri-
cardial effusion was massive and drawn off by pericardio-
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centesis. The diagnosis of metastatic RCC was made from
biopsy. The patient was referred to us for further investiga-
tions and treatment.
Echocardiography and magnetic resonance imaging re-
vealed a large mass that nearly obliterated the right ventric-
ular cavity and that invaded into the ventricular septum. The
septum was remarkably hypertrophied up to 29 mm, com-
pressing the left ventricular cavity. The intracavity mass
also involved right ventricular free wall and subvalvular
apparatus of tricuspid valve, extending into left ventricular
wall across around the apex (Figure 1). A systolic right ven-
tricular pressure was elevated to 55 mm Hg.
After admission, the patient deteriorated despite inotropic
support. Six days after admission, she developed low urine
output and orthopnea. Blood chemistry analysis showed
acute liver dysfunction and coagulopathy disorder. Uncon-
trollable heart failure necessitated percutaneous cardiopul-
monary support and emergency surgery.
Midsternotomy imaging revealed that the intramural tu-
mor mass occupied not only the entire anterior and diaphrag-
matic free wall of the right ventricle but also the apical wall
of the left ventricle. After cardioplegic arrest, the infundibu-
lar portion of the right ventricle was incised longitudinally.
The entire right ventricular cavity was filled with fragile
yellow-gray tumor, which had a stalk growing from the
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